Komori
Other Disclosures438AInfcurion,Inc.Information and Communications, Services and Others

アルファリア plans to launch “Pharma Trade Pay” (tentative name), a B2B payment service for the pharmaceutical industry, in partnership with Sumitomo Mitsui Card, on 7 October 2026.

Infcurion plans to launch “Pharma Trade Pay” (provisional name), an invoice card payment service for transactions between pharmaceutical manufacturers and pharmaceutical wholesalers, in collaboration with アルファリア and Sumitomo Mitsui Card. The service will maintain pharmaceutical wholesalers’ existing payment terms while shortening and standardizing pharmaceutical manufacturers’ collection period to as little as 30 days.

Worth reading
73In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
30
Days (shortest collection period)
Wording
Conditional
How definitive the wording is.

Announced details

Pharma Trade Pay (provisional name)Winvoice (invoice payment platform)
Applicable field (uses covered by this announcement)

Pharmaceutical industry. B2B payments between pharmaceutical manufacturers and pharmaceutical wholesalers.

Launch dateScheduled to launch from 7 October 2026
What the company reported numerically
Quantitative Effects

Pharmaceutical manufacturers’ collection period will be shortened and standardized to as little as 30 days. Pharmaceutical wholesalers will generally maintain their existing payment terms and bank transfer timing.

Relationship between the counterparty and the company
Infcurion,Inc.438A
Relationship with the Company

Infcurion, アルファリア and Sumitomo Mitsui Card will collaborate to build the service by combining their respective capabilities, expertise and resources. アルファリア is a wholly owned subsidiary of TOHO HOLDINGS CO.,LTD.

Counterpartyアルファリア株式会社Sumitomo Mitsui Card Company, Limited

アルファリア株式会社: Wholly owned subsidiary of TOHO HOLDINGS CO.,LTD. Head office: Chuo-ku, Tokyo. Established: 15 January 2014. Representative: Miura Yasumasa (三浦 康正), Representative Director, President and CEO. Business overview: Payment services, factoring services and related businesses., Sumitomo Mitsui Card Company, Limited: Head office: Koto-ku, Tokyo. Established: 26 December 1967. Representative: Sasaki Takeya (佐々木 丈也), Representative Director and President. Business overview: Credit card services, debit card, prepaid card and other payment services, loan services, guarantee services, consumer finance services, transaction services and other related businesses.

Registration number and expiry date

Trademark registration application pending (registration number and expiration date: not disclosed)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Announced details
ItemDetails
Names of Products / Services CoveredPharma Trade Pay (provisional name), Winvoice (invoice payment platform)
Counterpartyアルファリア株式会社, Sumitomo Mitsui Card Company, Limited
Counterparty overviewアルファリア株式会社: Wholly owned subsidiary of TOHO HOLDINGS CO.,LTD. Head office: Chuo-ku, Tokyo. Established: 15 January 2014. Representative: Miura Yasumasa (三浦 康正), Representative Director, President and CEO. Business overview: Payment services, factoring services and related businesses., Sumitomo Mitsui Card Company, Limited: Head office: Koto-ku, Tokyo. Established: 26 December 1967. Representative: Sasaki Takeya (佐々木 丈也), Representative Director and President. Business overview: Credit card services, debit card, prepaid card and other payment services, loan services, guarantee services, consumer finance services, transaction services and other related businesses.
Relationship with the CompanyInfcurion, アルファリア and Sumitomo Mitsui Card will collaborate to build the service by combining their respective capabilities, expertise and resources. アルファリア is a wholly owned subsidiary of TOHO HOLDINGS CO.,LTD.
Launch dateScheduled to launch from 7 October 2026
Applicable areaPharmaceutical industry. B2B payments between pharmaceutical manufacturers and pharmaceutical wholesalers.
Registration number and expiry dateTrademark registration application pending (registration number and expiration date: not disclosed)
Quantitative EffectsPharmaceutical manufacturers’ collection period will be shortened and standardized to as little as 30 days. Pharmaceutical wholesalers will generally maintain their existing payment terms and bank transfer timing.
Items this document does not state (10)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyLocationLocation scaleUsage historyImpact on Business PerformanceSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To address industry-specific challenges, including the lengthening and lack of standardization of collection periods between pharmaceutical manufacturers and pharmaceutical wholesalers, as well as the impact on wholesalers’ cash flow when changing payment methods.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
アルファリア plans to launch “Pharma Trade Pay” (tentative name), a B2B payment service for the pharmaceutical industry, in partnership with Sumitomo Mitsui Card, on 7 October 2026. | Infcurion,Inc. (438A) timely disclosure | Komori